Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Aurobindo Pharma's revenue share from ARV formulations FY 2013-2019

The share of revenue from antiretroviral formulations by Aurobindo Pharma Limited for fiscal year 2019 was five percent. The revenue generated by the company from ARV formulations was over 9.5 billion Indian rupees during financial year 2019.

Share of revenue from antiretroviral drug formulations by Aurobindo Pharma Limited from financial year 2013 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

August 2019

Region

India

Survey time period

FY 2013 to FY 2019

Supplementary notes

ARV denotes antiretroviral drug formulations.
India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "GlaxoSmithKline Pharmaceuticals Limited India"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.